海普瑞 港股通 空最新增减持 (2026-06-30) 官网 ( 09989.hk) | 14.88 | 0.47 | 3.74% (3.67%) | 上市时间2020-07-08股价4.40港币涨跌幅-0.45%成交金额274.63万港币换手率0.04%市值64.56亿港币H股市值9.68亿港币总股本14.67亿H股本2.20亿每手股数500上市至今年化投资收益率-18.68%港股通持仓占H股比例50.59% (4.79亿港币2026-07-21) | |||
| 所属三级行业药品 (恒生) | 市盈率 | 27.47 | 市净率 | 2.47 | 股息率 | 1.38% (1.37%) | 恒生:医疗保健业药品及生物科技药品 |
| 所属指数指数纳入纳出 | |||||||
| 同股同权 | 查看历史折扣 | ||||||
| 备注 (5): | 双击编辑备注 |
海普瑞(09989) - 历史董事名单
| # | 姓名 | 职衔 | 职位 | 委任日期 | 辞任日期 |
|---|---|---|---|---|---|
| 1 | 黃鵬 | Independent Non Executive Director | 2023-05-22 | -- | |
| 2 | 易銘 | Independent Non Executive Director | 2023-05-22 | -- | |
| 3 | 張平 | Executive Director | 2023-05-22 | -- | |
| 4 | 張斌 | Executive Director | 2021-05-26 | 2022-04-29 | |
| 5 | 孫暄 | Executive Director | 2020-02-01 | 2021-05-06 | |
| 6 | 呂川 | Independent Non Executive Director | 2019-12-01 | -- | |
| 7 | 王肇輝 | Independent Non Executive Director | 2017-07-01 | 2023-05-22 | |
| 8 | 李鋰 | Executive Director | Chairman | 2017-05-01 | -- |
| 9 | 李坦 | Executive Director | 2017-05-01 | -- | |
| 10 | 單宇 | Executive Director | 2017-05-01 | -- | |
| 11 | 陳俊發 | Independent Non Executive Director - A/F | 2017-05-01 | 2023-05-22 | |
| 12 | 步海華 | Non Executive Director | 2017-05-01 | 2021-04-17 |